Fulminant Hepatic Failure Following Initiation of Abiraterone in Metastatic Prostate Cancer: A Fatal Adverse Drug Reaction
{{output}}
Background: Abiraterone acetate is widely used in metastatic castration-resistant prostate cancer and is generally considered safe. Hepatotoxicity is a known adverse effect, but fulminant liver failure remains a rare and potentia... ...